STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GPCR STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

休市中 07-19 16:00:00 EDT

37.44

-0.46

-1.21%

盘后37.44

+0.000.00%

19:38 EDT

最高38.97	最低37.06	成交量78.10万
今开38.05	昨收37.90	日振幅5.03%
总市值20.85亿	流通市值14.38亿	总股本5,569万
成交额2,946万	换手率2.03%	流通股本3,840万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":37.44,"timestamp":1721419200000,"preClose":37.9,"halted":0,"volume":780996,"hourTrading":{"tag":"盘后","latestPrice":37.44,"preClose":37.44,"latestTime":"19:38 EDT","volume":4901,"amount":183524.99,"timestamp":1721432290942},"delay":0,"floatShares":38404400,"shares":55688095,"eps":-2.303584,"marketStatus":"休市中","marketStatusCode":7,"change":-0.46,"latestTime":"07-19 16:00:00 EDT","open":38.05,"high":38.965,"low":37.06,"amount":29459567.427959997,"amplitude":0.050264,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.303584,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":0,"listingDate":1675400400000,"adjPreClose":37.9,"adrRate":3,"preHourTrading":{"tag":"盘前","latestPrice":39.2,"preClose":37.9,"latestTime":"08:10 EDT","volume":210,"amount":8234.00046,"timestamp":1721391032477},"postHourTrading":{"tag":"盘后","latestPrice":37.44,"preClose":37.44,"latestTime":"19:38 EDT","volume":4901,"amount":183524.99,"timestamp":1721432290942},"volumeRatio":0.461448,"impliedVol":0.7764,"impliedVolPercentile":0.2935},"requestUrl":"/m/hq/s/GPCR","defaultTab":"news","newsList":[{"id":"2452861160","title":"BUZZ-罗氏试验性药物的早期数据令肥胖药生产商望而却步","url":"https://stock-news.laohu8.com/highlight/detail?id=2452861160","media":"Reuters","labels":["Business Data"],"top":-1,"share":"https://www.laohu8.com/m/news/2452861160?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:11","pubTimestamp":1721236299,"startTime":"0","endTime":"0","summary":"** 瑞士制药商罗氏  报告了一种试验性每日一次肥胖药CT-996的早期数据 ，该药帮助 患者在四周内平均减轻了6.1%的体重。** Structure 公司的口服肥胖症药物在一项中期研究中帮助患者平均减轻了 6.2% 的体重，而 VKTX 公司预计将于今年开始对其片剂进行中期研究。** 经纪公司 BMO Capital 称，虽然罗氏的早期数据似乎与 GPCR 和 LLY 的实验药物相当，但要进行有意义的比较，还需要详细的耐受性数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0466842654.USD","LU0122379950.USD","LU0320765059.SGD","IE0009355771.USD","LU0820561909.HKD","LU0385154629.USD","VKTX","LU0256863902.USD","IE00BK4W5M84.HKD","LU1267930730.SGD","BK4534","LU0061475181.USD","BUZZ","IE00B1BXHZ80.USD","LU1035775433.USD","LU0238689110.USD","LU0672654240.SGD","LU0097036916.USD","LU0882574139.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1064131342.USD","LU0640476718.USD","LU1280957306.USD","LU0471298777.SGD","LU0708995401.HKD","IE00BK4W5L77.USD","LU1057294990.SGD","LU0094547139.USD","LU0417517546.SGD","LU0689472784.USD","LU1023059063.AUD","LU1712237335.SGD","LU0109391861.USD","BK4581","BK4533","IE00B4R5TH58.HKD","LU0820561818.USD","BK4007","LU1069344957.HKD","LU0198837287.USD","GPCR","LLY","LU0058720904.USD","LU1623119135.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","BK4516"],"gpt_icon":1},{"id":"2452071163","title":"背景资料-减肥药开发商排队开发价值 1500 亿美元的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2452071163","media":"Reuters","labels":["Product Release"],"top":-1,"share":"https://www.laohu8.com/m/news/2452071163?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:51","pubTimestamp":1721227909,"startTime":"0","endTime":"0","summary":"Wegovy与诺和诺德的糖尿病药物Ozempic使用相同的活性成分，于2021年获得批准。该公司报告说，在12月Zepbound上市的头几周， ，销售额达1.758亿美元。根据这项研究的数据，经过13周的治疗，VK2735帮助患者实现了高达14.7%的平均体重减轻。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","AMGN","LU1623119135.USD","IE00BJLML261.HKD","IE0002141913.USD","NVO","GB00BDT5M118.USD","PFE","LU1894683348.USD","LU0882574139.USD","LU1804176565.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1066051498.USD","LU1069344957.HKD","LU2112291526.USD","LU0882574055.USD","LU0079474960.USD","LU0820561818.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","OPK","BK4592","IE0009355771.USD","LU0097036916.USD","LU0096364046.USD","LU1066053197.SGD","LU0109394709.USD","LU0466842654.USD","ALT","LU1878469433.USD","SG9999001176.SGD","LU0471298694.HKD","LU0114720955.EUR","IE0004445239.USD","IE00BKVL7J92.USD","LU1712237335.SGD","LU0943347566.SGD","LU1551013342.USD","SG9999011175.SGD","BK4581","LU2242652126.USD","LU1551013425.SGD","BK4588","GPCR","LU0321505868.SGD","SG9999003800.SGD","LU1061106388.HKD","LLY","LU0385154629.USD"],"gpt_icon":1},{"id":"2452579631","title":"硕迪生物盘中异动 快速下跌13.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452579631","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452579631?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:32","pubTimestamp":1721223120,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时32分，硕迪生物股票出现波动，股价快速跳水13.26%。截至发稿，该股报38.74美元/股，成交量16.4822万股，换手率0.29%，振幅3.13%。硕迪生物股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Aditxt, Inc.、Longeveron Inc.、Aptevo Therapeutics Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为661.65%、477.02%、100.61%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Aditxt, Inc.、Seres Therapeutics, Inc.，振幅分别为13.22%、13.13%、10.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071721320095cedd3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071721320095cedd3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LGVN","GPCR","BK4139"],"gpt_icon":1},{"id":"2451161449","title":"硕迪生物盘中异动 早盘快速上涨5.30%报46.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451161449","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451161449?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:35","pubTimestamp":1721140556,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时35分，硕迪生物股票出现异动，股价大幅拉升5.30%。截至发稿，该股报46.88美元/股，成交量28.6743万股，换手率0.50%，振幅4.36%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162235569681d36a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162235569681d36a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR"],"gpt_icon":1},{"id":"2451626833","title":"硕迪生物盘中异动 早盘大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451626833","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451626833?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:16","pubTimestamp":1721052976,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时16分，硕迪生物股票出现异动，股价快速上涨5.13%。截至发稿，该股报46.13美元/股，成交量14.3722万股，换手率0.25%，振幅4.56%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152216169681cd3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152216169681cd3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007"],"gpt_icon":0},{"id":"2450708531","title":"硕迪生物盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450708531","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450708531?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:35","pubTimestamp":1720794947,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时35分，硕迪生物股票出现波动，股价大幅上涨5.12%。截至发稿，该股报44.95美元/股，成交量33.5846万股，换手率0.59%，振幅6.27%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.84%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223548aef97cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223548aef97cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR"],"gpt_icon":0},{"id":"2450357518","title":"BUZZ-辉瑞推进减肥药开发的举动拖累了一些药品开发商","url":"https://stock-news.laohu8.com/highlight/detail?id=2450357518","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450357518?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:07","pubTimestamp":1720703263,"startTime":"0","endTime":"0","summary":" (更新)    7月11日 - ** 减肥药开发商Viking Therapeutics   股价盘前下跌4.3%至55.50美元** 辉瑞  计划在今年下半年将其实验性肥胖药danuglipron的改良版、每日一次版推进到临床试验中。** 丹麦公司 Zealand Pharma A/S    下跌 4.5% ** 基于其减肥药物在  早期的积极数据，Zealand 预计将在 2024 年下半年启动一项中期试验** Altimmune  和Structure Therapeutics  的股价在收盘前小幅下跌** ALT和GPCR的肥胖症实验药物均已成功完成  中期试验 ** 截至上次收盘，VKTX的股价上涨了两倍多，ZELA上涨了一倍多，ALT下跌了33.5%，GPCR上涨了2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","ALT","IE00BLSP4239.USD","BK4534","LU0058720904.USD","LU1894683348.USD","BK4550","BK4585","LU1894683264.USD","SG9999001176.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4588","BK4592","LU0868494617.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","PFE","SG9999002232.USD","LU0234572021.USD","BUZZ","SG9999001176.SGD","LU0170899867.USD","GPCR","SG9999002224.SGD","IE0002270589.USD","LU1023059063.AUD","BK4581","BK4139","LU0122379950.USD","LU1057294990.SGD","LU0321505439.SGD","LU1878469433.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","BK4533","LU1883839398.USD","SG9999003800.SGD","LU0456855351.SGD","SG9999011175.SGD","LU1066051498.USD","VKTX","IE00BBT3K403.USD","BK4568","BK4007","LU0289739699.SGD"],"gpt_icon":0},{"id":"2450726359","title":"BUZZ-辉瑞推进减肥药的举措拖累了一些开发商","url":"https://stock-news.laohu8.com/highlight/detail?id=2450726359","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450726359?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:15","pubTimestamp":1720700140,"startTime":"0","endTime":"0","summary":" (更新)    7月11日 - ** 减肥药开发商Viking Therapeutics   股价盘前下跌4.8%至55.22美元** 辉瑞  计划在今年下半年将其实验性肥胖药danuglipron的改良版、每日一次版推进到临床试验中。** 今年 3 月，VKTX 公司称，其实验性口服药物  在一项小型早期试验中对志愿者进行了测试，结果显示其体重降低了 3.3%。** ALT 和 GPCR 的肥胖症实验药物均已成功完成  中期试验 ** 截至上次收盘，VKTX 的股价上涨了两倍多，ALT 下跌了 33.5%，GPCR 则上涨了 2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0289739699.SGD","LU0321505439.SGD","BK4581","SG9999013999.USD","VKTX","BK4550","LU1894683348.USD","BK4007","SG9999011175.SGD","BUZZ","IE00BBT3K403.USD","BK4592","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1894683264.USD","LU0170899867.USD","SG9999002224.SGD","LU1066051498.USD","LU0868494617.USD","BK4533","LU0234572021.USD","SG9999001176.SGD","SG9999001176.USD","BK4585","IE0002270589.USD","GPCR","BK4568","IE00BLSP4239.USD","BK4139","LU1878469433.USD","SG9999003800.SGD","ALT","LU0058720904.USD","IE00B19Z3581.USD","LU0321505868.SGD","PFE","BK4588","SG9999002232.USD","SGXZ57979304.SGD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0122379950.USD","LU1883839398.USD","LU0456855351.SGD"],"gpt_icon":0},{"id":"2450024829","title":"硕迪生物盘中异动 大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450024829","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450024829?lang=zh_cn&edition=full","pubTime":"2024-07-09 23:11","pubTimestamp":1720537917,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日23时11分，硕迪生物股票出现波动，股价大幅拉升5.13%。截至发稿，该股报39.14美元/股，成交量11.8248万股，换手率0.21%，振幅5.53%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709231157aef8be84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709231157aef8be84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR"],"gpt_icon":0},{"id":"2446755903","title":"硕迪生物盘中异动 急速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446755903","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446755903?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:42","pubTimestamp":1719499379,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时42分，硕迪生物股票出现异动，股价大幅拉升5.02%。截至发稿，该股报39.78美元/股，成交量23.0385万股，换手率0.40%，振幅5.49%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627224259aef6f2ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627224259aef6f2ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007"],"gpt_icon":0},{"id":"2446016396","title":"硕迪生物盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446016396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446016396?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:52","pubTimestamp":1719409969,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时52分，硕迪生物股票出现波动，股价大幅下跌5.08%。截至发稿，该股报37.93美元/股，成交量12.0079万股，换手率0.21%，振幅4.83%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626215249af8f5809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626215249af8f5809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR"],"gpt_icon":0},{"id":"2446478738","title":"硕迪生物盘中异动 早盘急速跳水5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446478738","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446478738?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:15","pubTimestamp":1719324948,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时15分，硕迪生物股票出现波动，股价急速下跌5.27%。截至发稿，该股报41.38美元/股，成交量38.7356万股，换手率0.68%，振幅4.66%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.61%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625221548941f0f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625221548941f0f25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR"],"gpt_icon":0},{"id":"2446886149","title":"硕迪生物盘中异动 急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446886149","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446886149?lang=zh_cn&edition=full","pubTime":"2024-06-25 03:43","pubTimestamp":1719258228,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日03时43分，硕迪生物股票出现异动，股价快速下跌5.07%。截至发稿，该股报43.26美元/股，成交量115.078万股，换手率2.02%，振幅4.92%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625034348aef65776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625034348aef65776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007"],"gpt_icon":0},{"id":"2443567630","title":"硕迪生物盘中异动 大幅跳水5.00%报49.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443567630","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443567630?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:22","pubTimestamp":1718374972,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时22分，硕迪生物股票出现异动，股价快速下跌5.00%。截至发稿，该股报49.06美元/股，成交量13.7643万股，换手率0.24%，振幅5.71%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-25.99百万美元，每股收益-0.56美元，毛利-658927.53美元，市盈率-21.94倍。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614222252af8da37a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614222252af8da37a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","GPCR","BK4139","BK4007"],"gpt_icon":0},{"id":"2442331443","title":"硕迪生物盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442331443","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442331443?lang=zh_cn&edition=full","pubTime":"2024-06-12 00:55","pubTimestamp":1718124957,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日00时55分，硕迪生物股票出现波动，股价大幅下挫5.01%。截至发稿，该股报50.26美元/股，成交量76.7262万股，换手率1.34%，振幅6.90%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为0.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612005557968136b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612005557968136b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007"],"gpt_icon":0},{"id":"2441712514","title":"BUZZ--美国股票走势-罗宾hood、JM Smucker、Novavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2441712514","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441712514?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:18","pubTimestamp":1717679913,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      6月6日 - 标普500指数和道指期货周四在震荡交投中走低，此前失业救济金申请数据显示美国劳动力市场日益疲软，而纳斯达克指数期货表现出色，原因是人工智能热门股Nvidia的上涨提振了科技板块的乐观情绪。美东时间9:01，道指电子盘  下跌0.01%，报38881点。标普500指数小型股  上涨0.01%，报5366.5点；纳斯达克100指数小型股  上涨0.11%，报19095点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMAR","GPCR","ACHR","LU1861217088.USD","BK4200","IE00BFSS7M15.SGD","LU0061475181.USD","LU1861220207.SGD","LPG","IE0009356076.USD","LU0320765059.SGD","DINO","BK4587","BK4144","NVDA","BK4588","LU0823411888.USD","DLTR","IE00BMPRXR70.SGD","HOOD","FIVE","BK4543","VSCO","SJM","MPC","LULU","BK4212","BK4549","BUZZ","COF","BK4127","ABM","BK4023","BK4547","BK4155","VNDA","PBF","BK4220","BK4548","BK4166","ANNX","DK","CXM","LU0348723411.USD","VSTO","LU0276348264.USD","BIG","LU0456854461.SGD","NVAX","LU0266512127.USD"],"gpt_icon":0},{"id":"2441271680","title":"BUZZ-Structure Therapeutics 因增资 4.76 亿美元而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2441271680","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441271680?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:17","pubTimestamp":1717676223,"startTime":"0","endTime":"0","summary":"    6月6日 - ** Structure Therapeutics  公司增资后，股价在盘前交易中下跌3.6%，报54.49美元。** 该公司在周三晚些时候宣布定价 ，以 52.50 美元的价格发行约 910 万股美国存托凭证，总收益约为 4.76 亿美元。** 发售规模从 800 万股美国存托凭证扩大至 910 万股美国存托凭证，定价较上一交易日折价 6.7** GPCR 的肥胖药丸在中期研究中超出华尔街预期  后，该公司股价在周一大涨 54% 至 52.74 美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","LU1668664300.SGD","BK4550","BK4007","BK4552","BK4127","IE00BSNM7G36.USD","BK4585","BK4504","GPCR","LU0106831901.USD","BK4533","BK4588"],"gpt_icon":0},{"id":"2440400265","title":"背景资料-减肥药开发商希望加入潜在的千亿美元市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2440400265","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440400265?lang=zh_cn&edition=full","pubTime":"2024-06-04 18:08","pubTimestamp":1717495707,"startTime":"0","endTime":"0","summary":"不过，还有其他几家药物开发商也正准备加入这一行列。Wegovy与诺和诺德的糖尿病药物Ozempic使用相同的活性成分，于2021年获得批准。该公司报告说，在12月Zepbound上市的头几周， ，销售额达1.758亿美元。有关这种药物与人体相互作用的数据预计将于明年公布。罗氏表示，新收购的候选药物已完成早期试验，准备在三个试验阶段中的第二个阶段进行人体试验。根据这项研究的数据，经过13周的治疗，VK2735帮助患者实现了高达14.7%的平均体重减轻。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","LU0672654240.SGD","BK4532","BK4534","BK4007","LU0882574055.USD","LU2468319806.SGD","LU2491049909.HKD","LU2264538146.SGD","NVO","OPK","LU2242646821.SGD","AMGN","LU1571399168.USD","SG9999001440.SGD","LU0061475181.USD","LU0320765059.SGD","LU1988902786.USD","ALT","LU0708995401.HKD","PFE","BK4533","IE0004445239.USD","LLY","IE00BJT1NW94.SGD","LU1814569148.SGD","LU0238689110.USD","LU1804176565.USD","LU1878469433.USD","LU0256863811.USD","LU1023059063.AUD","LU1551013342.USD","LU1551013425.SGD","GPCR","LU0079474960.USD","LU0122379950.USD","BK4566","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0289739699.SGD","LU1280957306.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0417517546.SGD","GB00BDT5M118.USD","LU0058720904.USD","LU0868494617.USD","LU2237438978.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2440547009","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440547009","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440547009?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":"    路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻             * Brixmor Property Group Inc   ：高盛将该公司列入其在美上市公司信用评级名单              * 霍尼韦尔国际公司  ：加拿大皇家银行将目标价从222美元下调至218美元              * 西蒙地产集团  ：高盛将其股票从美国定罪名单中删除              * Stericycle Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4155","QCOM","TGT","EQT","IE00BMG7P587.USD","SRE","GMAB","HON","FWONK","GTLB","LU1621768115.EUR","ARWR","S","FSLR","HHH","BK4080","BWMN","SPG","LU0823414478.USD","HUM","SO","CMCO","RIOT","BK4154","BK4082","TER","AGIO","BK4532","IE00BMG7P694.USD","BRX","TOL","BK4539","BA","LU1621767810.EUR","ZS","LU1267930227.SGD","LU1621767737.EUR","SG9999014013.SGD","CLSK","LU2286300806.USD","SRCL","SGC","BK4088","BK4187","MARA","ENPH","GPCR","EW"],"gpt_icon":0},{"id":"2440470047","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440470047","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440470047?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":"    路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻             * Brixmor Property Group Inc   ：高盛将该公司列入其在美上市公司信用评级名单              * 霍尼韦尔国际公司  ：加拿大皇家银行将目标价从222美元下调至218美元              * 西蒙地产集团  ：高盛将其股票从美国定罪名单中删除              * Stericycle Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMCO","IE00BMG7P694.USD","GMAB","EQT","BK4532","BA","AGIO","ARWR","BK4082","LU2286300806.USD","TGT","FWONK","LU1621768115.EUR","IE00BMG7P587.USD","LU1267930227.SGD","CLSK","SPG","SGC","FSLR","ZS","S","ENPH","LU1621767810.EUR","GTLB","SG9999014013.SGD","BRX","HHH","HON","BK4088","TER","BWMN","SRE","GPCR","BK4539","BK4080","MARA","SRCL","TOL","EW","LU0823414478.USD","BK4155","QCOM","LU1621767737.EUR","BK4187","BK4154","RIOT","SO","HUM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.structuretx.com","stockEarnings":[{"period":"1week","weight":-0.1468},{"period":"1month","weight":-0.2121},{"period":"3month","weight":0.0297},{"period":"6month","weight":-0.0817},{"period":"1year","weight":0.1048},{"period":"ytd","weight":-0.0815}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕迪生物公司于2019年2月在开曼群岛成立，在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司，旨在开发和提供新型口服疗法，以治疗各种慢性疾病，满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识，使公司能够开发口服小分子疗法，用于治疗各种疾病，包括影响代谢、心血管和肺系统的疾病。","exchange":"NASDAQ","name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","nameEN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD,GPCR,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎国际,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股价,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股市,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票价格,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票交易,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票购买,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}